This is a study for people with chronic kidney disease and type 1 diabetes. In this study, we want to learn more about the effectiveness and safety of a kidney drug called finerenone compared to a placebo.
At each clinic visit, you will meet with members of the study team to discuss the tolerance of the study drug, labs will be drawn at each visit, a physical assessment will be completed, and the effectiveness of the study intervention will be discussed. The study will require lab draws, urinalysis, a 12 lead ECG, and the willingness to continue with study requirements.
$100 for in clinic visits, healthcare team oversight of your health status, diabetes and kidney disease management
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA
Klara Klein
Medicine-Endocrinology
Clinical or Medical
Interventional
Chronic Conditions
Diabetes
Kidneys and Liver
UNC or UNC Health employees
UNC Students (undergrad, grad, professional)
23-1775
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
